It’s the moment software engineers, executives and investors turn their work over to Anthropic’s Claude AI—and then witness a thinking machine of shocking capability, even in an age awash in powerful ...
Bro Man's Sammiches was named in Mashed's "Best Burger Joints In Pennsylvania" list. This is the second national recognition for the restaurant from the same online food site. Owner Stephen Stanbro ...
Over the holidays, Alex Lieberman had an idea: What if he could create Spotify “Wrapped” for his text messages? Without writing a single line of code, Lieberman, a co-founder of the media outlet ...
On Monday, Anthropic announced a new tool called Cowork, designed as a more accessible version of Claude Code. Built into the Claude Desktop app, the new tool lets users designate a specific folder ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Hoyoverse just wrapped up the Genshin Impact version "Luna 4" (or 6.3, as some others would liek to call it) preview livestream, showing off all sorts of details about the upcoming patch. Most ...
Nathan Round, part of GameRant's talented Game Guides Team, is the leading voice for Call of Duty guides. From meta loadouts to the best weapons for each season, he takes pride in crafting top-notch ...
A viral TikTok video labeled a man rapid-swiping on a dating app as a "passport bro" after spotting him at a Singapore airport. Men like this travel to foreign countries, often in Asia and Latin ...
Sam Altman’s decision to declare a “code red” at OpenAI earlier this month may have caught the industry’s attention, but it wasn’t a first for the artificial intelligence company. The San ...
Google made another change to the JavaScript SEO documentation help document to explain and clarify JavaScript execution on non-200 HTTP status codes. The change. Google wrote, “All pages with a 200 ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...